金斯瑞生物科技2024年利润约29亿美元 毛利约2.72亿美元

财中社
12 Mar

3月12日,金斯瑞生物科技(01548)发布截至2024年12月31日止年度之年度业绩公告。报告期内,公司的整体收益约为5.95亿美元,较上期的约5.61亿美元增加6.1%。毛利约为2.72亿美元,较上期保持稳定。报告期内,公司录得的利润约为29亿美元,而上期则为亏损约为3.55亿美元。细胞疗法业务解除合并的收益约为32亿美元,带来了显著的利润增长。在财务回顾中,持续经营业务的净亏损为1.74...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10